H.R. 7366: Dietary Supplement Regulatory Uniformity Act
This bill, known as the Dietary Supplement Regulatory Uniformity Act, aims to clarify the authority of the Food and Drug Administration (FDA) over the regulation of dietary supplements. Here are the main points of what the bill proposes:
Clarification of Preemptive Authority
The bill amends the existing Federal Food, Drug, and Cosmetic Act to assert the FDA's preemption over state laws regarding dietary supplements. This means that:
- No state or local government may put in place their own rules about dietary supplements that are different or additional to federal regulations established by the FDA.
- States may only establish stricter regulations if they apply for an exemption from the FDA. This exemption requires that:
- The state regulation is stricter than federal requirements.
- The regulation addresses a compelling local condition.
- Following the state regulation does not result in non-compliance with federal law.
Purpose of the Bill
The intent behind the bill is to create a more uniform regulatory landscape for dietary supplements across the United States. By ensuring that all states follow the same federal guidelines, the bill seeks to:
- Reduce confusion and complexity in the dietary supplement market.
- Ensure that consumers have consistent information about dietary supplements regardless of their location.
- Streamline the regulatory process for dietary supplement manufacturers, potentially leading to increased efficiency.
Impact on States
Under this legislation, states will have limited ability to impose their own laws concerning dietary supplements. They would need to follow federal guidelines unless they can successfully justify and obtain an exemption for stricter rules.
Benefit to Consumers
This bill aims to protect consumers by providing a clear set of standards for dietary supplements that apply nationwide, which could help ensure product safety and reliability across different states.
Implementation and Oversight
The FDA will oversee the implementation of these regulations. They will have the authority to grant exemptions to states, which adds a layer of federal oversight to state dietary supplement regulations.
Relevant Companies
- AMRN: Amarin Corporation, which specializes in dietary supplements, may need to adjust its compliance strategies due to the more stringent uniform federal regulations.
- NVAX: Novavax, Inc. may also be impacted if they have dietary supplement products, as they will face federal regulations that supersede state laws.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 04, 2026 | Introduced in House |
| Feb. 04, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.